Transformational acquisition expected to accelerate EBITDA margin expansion MRP to continue delivering services through existing operating companies and brands Kelly […]
BOSTON, June 03, 2024 (GLOBE NEWSWIRE) — Entrada Therapeutics, Inc. (Nasdaq: TRDA) is a clinical-stage biopharmaceutical company aiming to transform […]